Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Cipla Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (74)
Cancellation by sponsor (28)
Prescription medicine registration (2)

Date

(-) 2017 (104)
2026 (9)
2025 (97)
2024 (73)
2023 (99)
2022 (70)
2021 (65)
2020 (112)
2019 (18)
2018 (68)
2016 (27)
2015 (33)
2014 (13)
2013 (6)
2012 (4)
2011 (6)
2010 (16)
2009 (4)
2008 (3)
2007 (5)
2006 (2)
2005 (2)
2004 (2)
2003 (3)
2002 (2)
2001 (3)
2000 (1)
1999 (2)
1998 (1)
1996 (1)

Search

Filters applied:

2017

Clear all

Sponsor content

104 result(s) found, displaying 71 to 80

CIPLA LINEZOLID linezolid 600 mg film-coated tablet blister pack (272903)

24 January 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CIPLA LINEZOLID linezolid 600 mg film-coated tablet blister pack.
LINEZOLID CIP linezolid 600 mg film-coated tablet bottle (272904)

24 January 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LINEZOLID CIP linezolid 600 mg film-coated tablet bottle.
LINEZOLID CIP linezolid 600 mg film-coated tablet blister pack (272905)

24 January 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LINEZOLID CIP linezolid 600 mg film-coated tablet blister pack.
CIPLA LINEZOLID linezolid 600 mg film-coated tablet bottle (273047)

24 January 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CIPLA LINEZOLID linezolid 600 mg film-coated tablet bottle.
IRINOTECAN - SMD irinotecan hydrochloride trihydrate 100 mg / 5 mL injection vial Cancelled under s30(1)(c)

18 December 2017

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
IRINOTECAN - SMD irinotecan hydrochloride trihydrate 40 mg / 2 mL injection vial Cancelled under s30(1)(c)

18 December 2017

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
BOSENTAN CIPLA, BOSENTAS, BOSENCIP (Cipla Australia Pty Ltd)

7 December 2017

Prescription medicine registration

Active ingredients: bosentan (as monohydrate).
CASPOCIP, CASPOFUNGIN CA, CASPOFUNGIN CIPLA (Cipla Australia Pty Ltd)

1 December 2017

Prescription medicine registration

Active ingredients: caspofungin (as acetate).
Amcal Nappy Rash Ointment Pro-Vitamin B5 dexpanthenol 50mg/g Cancelled under s30(1)(c)

29 June 2017

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
Amcal Throat and Nose Lozenge (sugar free) with Vitamin C (Menthol and Eucalyptus) Cancelled under s30(1)(c)

29 June 2017

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd

Pages

First page
Previous page
…
Page 3
Page 4
Page 5
Page 6
Page 7
Current page 8
Page 9
Page 10
Page 11
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.